Journal of Pediatric Surgery
Volume 45, Issue 7 , Pages 1445-1454, July 2010

Gene expression analysis in hypoplastic lungs in the nitrofen model of congenital diaphragmatic hernia

  • Carmen Mesas Burgos

      Affiliations

    • Department of Woman and Child Health, Division for Peadiatric Surgery, Karolinska Institutet Stockholm, Sweden
    • Corresponding Author InformationCorresponding author.
  • ,
  • Andreas Ringman Uggla

      Affiliations

    • Department of Woman and Child Health, Division for Peadiatric Surgery, Karolinska Institutet Stockholm, Sweden
  • ,
  • Fredrik Fagerström-Billai

      Affiliations

    • Bioinformatics and Expression Analysis Core Facility, Department of Biosciences and Nutrition, Karolinska Institutet Stockholm, Sweden
  • ,
  • Ann-Christine Eklöf

      Affiliations

    • Department of Woman and Child Health, Division for Peadiatric Surgery, Karolinska Institutet Stockholm, Sweden
  • ,
  • Björn Frenckner

      Affiliations

    • Department of Woman and Child Health, Division for Peadiatric Surgery, Karolinska Institutet Stockholm, Sweden
  • ,
  • Magnus Nord

      Affiliations

    • Department of Medicine, Division for Respiratory Medicine, Karolinska Institutet Stockholm, Sweden

Received 21 July 2009; received in revised form 25 September 2009; accepted 25 September 2009.

Abstract 

Background

Pulmonary hypoplasia and persistent pulmonary hypertension are the main causes of mortality and morbidity in newborns with congenital diaphragmatic hernia (CDH). Nitrofen is well known to induce CDH and lung hypoplasia in a rat model, but the mechanism remains unknown. To increase the understanding of the underlying pathogenesis of CDH, we performed a global gene expression analysis using microarray technology.

Methods

Pregnant rats were given 100 mg nitrofen on gestational day 9.5 to create CDH. On day 21, fetuses after nitrofen administration and control fetuses were removed; and lungs were harvested. Global gene expression analysis was performed using Affymetrix Platform and the RAE 230 set arrays. For validation of microarray data, we performed real-time polymerase chain reaction and Western blot analysis.

Results

Significantly decreased genes after nitrofen administration included several growth factors and growth factors receptors involved in lung development, transcription factors, water and ion channels, and genes involved in angiogenesis and extracellular matrix. These results could be confirmed with real-time polymerase chain reaction and protein expression studies.

Conclusions

The pathogenesis of lung hypoplasia and CDH in the nitrofen model includes alteration at a molecular level of several pathways involved in lung development. The complexity of the nitrofen mechanism of action reminds of human CDH; and the picture is consistent with lung hypoplasia and vascular disease, both important contributors to the high mortality and morbidity in CDH. Increased understanding of the molecular mechanisms that control lung growth may be the key to develop novel therapeutic techniques to stimulate pre- and postnatal lung growth.

Key words: Congenital diaphragmatic hernia, Lung hypoplasia, Persistent pulmonary hypertension, Nitrofen, Gene expression analysis, Lung growth, Lung development

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-3468(09)00764-7

doi:10.1016/j.jpedsurg.2009.09.023

Journal of Pediatric Surgery
Volume 45, Issue 7 , Pages 1445-1454, July 2010